Biomedica

What Biomedica does

Biomedica Medizinprodukte GmbH is an Austrian biotechnology company founded in 1988 that develops and manufactures high-quality immunoassays for pre-clinical and clinical biomarker research. The company is headquartered at Divischgasse 4, 1210 Vienna, Austria, with development and production facilities in Bratislava, Slovakia (approximately one hour from Vienna), enabling tight coordination of production and analytical measurement. Biomedica is a privately held subsidiary of the publicly traded AddLife Group, a Swedish Life Science and Medical Device conglomerate.

The company's core technology is the sandwich ELISA (Enzyme-Linked Immunosorbent Assay) format, supplemented by Luminex multiplex assays, microRNA analysis, and glycan profiling. Its catalog includes over 100 validated biomarker assays spanning bone metabolism (FGF23, Sclerostin, DKK1, RANKL, OPG), cardiovascular (NT-proBNP, Angiopoietin-2, Endothelin-1, LRG1, NT-proANP, NT-proCNP), oncology (Periostin, Semaphorin 4D, Endostatin), nephrology, cytokines (IL-6), metabolic disease, neurology, and infectious disease. Differentiating technical features include serum-based standards spiked with recombinant analyte to mimic clinical samples, epitope-mapped antibody pairs developed through partner The Antibody Lab's BestCell expression system, and assays designed for direct measurement without pre-dilution. Manufacturing is ISO 9001:2015 certified (TUV, valid through 2028-08-31), GMP/GLP compliant, CE marked for IVD products, and validated under FDA, EMEA, and ICH guidelines.

Biomedica operates a sales-led B2B model with three revenue streams: catalog sales of research-use-only ELISA kits at approximately €670–€675 per 96-well kit, analytical testing services (Luminex, ELISA, microRNA, glycan profiling) performed at the Bratislava facility, and custom contract assay development. Products ship worldwide from Vienna either directly to customers or via selected local distributors on all continents. Customers include top-ranking research institutions, pharmaceutical industry laboratories, well-known contract research organizations (CROs), and clinical laboratories. Strategic distribution partnerships with TAmiRNA (microRNA kits), Fianostics (FluoBolt fluorescence assays), and Glycotechnica (LecChip glycan profiling) extend the portfolio into adjacent modalities under the Biomedica commercial umbrella.

Name

Biomedica

Legal name

Biomedica Medizinprodukte GmbH

Website

https://bmgrp.com

Company type

Private

Founded year

1988

Operating status

Operating

Headcount range

101–250 employees

Short description

Biomedica Medizinprodukte GmbH is an Austrian biotechnology company that develops and manufactures over 100 ELISA-based biomarker immunoassays and offers analytical testing services for pre-clinical and clinical research, serving pharmaceutical laboratories, CROs, and research institutions worldwide as a subsidiary of AddLife Group.

Ownership category

akta.pro rank

Headquarters

HQ city

Vienna

HQ country

Austria

HQ region

Europe

Offices2 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Personnel, Technology or R&D, Supply Chain, Operations, Marketing or Sales

Revenue model

1. ELISA and Immunoassay Kit Sales: Sale of research-use-only ELISA kits and immunoassay products for biomarker detection. Products include Rat NT-proBNP ELISA (€670/kit), Bioactive Sclerostin ELISA (€675/kit), DKK1 ELISA, and over 100 biomarker assays across therapeutic areas including bone metabolism, cardiovascular, oncology, and nephrology.
2. Analytical Testing Services: Custom analytical testing services for all Biomedica and other manufacturers' ELISAs, Luminex assays, microRNA analysis, and glycan profiling performed at Bratislava facility.
3. Contract Development Services: Custom immunoassay development services for customers, institutions, and companies requiring novel tests or professional advancement of existing tests.

Pricing tiers

Go-to-market motion1 record

Distribution channels3 records

Marketing channels5 records

Core offering

Biomedica develops, manufactures, and distributes high-quality immunoassay kits (primarily ELISA) for quantitative biomarker detection in pre-clinical and clinical research. The company sells over 100 biomarker assays across bone metabolism, cardiovascular, oncology, nephrology, cytokines, and other research areas. In addition to products, Biomedica offers contract analytical testing services — including ELISA, Luminex multiplex, microRNA, and glycan profiling — and custom assay development at its Bratislava facility.

Product overview

Biomedica is a developer and manufacturer of superior quality immunoassays for pre-clinical and clinical applications. The product portfolio centers on ELISA (Enzyme Linked Immunosorbent Assay) kits across multiple research areas including Bone Metabolism (FGF23, Sclerostin, DKK1, OPG, RANKL, Periostin), Cardiovascular (NT-proBNP, BNP Fragment, Endothelin-1, NT-proANP, NT-proCNP, Angiopoietin-2, LRG1), Cytokines (IL-6), and other biomarkers. All kits are provided as complete 96-well sandwich ELISA sets with serum-based standards, controls, and protocol booklets. In addition to products, Biomedica offers contract analytical testing services including Luminex multiplex, ELISA, microRNA analysis, and glycan profiling, as well as custom assay development for customers requiring novel tests.

Differentiator

Problem solved

Functional benefit

Products and services

• Rat NT-proBNP ELISA Kit (BI-1204R) 96-well sandwich ELISA kit (3.5-hour assay) for quantitative determination of rat NT-proBNP in serum or plasma; low sample volume (10 µl/well), kit control included. For research use.
• Bioactive Sclerostin ELISA Kit (BI-20472) 96-well sandwich ELISA kit (3.5-hour assay) for quantitative determination of bioactive Sclerostin in human serum, EDTA-plasma, and citrate plasma, using antibodies targeting the receptor binding region.
• Human DKK1 ELISA Kit (BI-20413) 96-well sandwich ELISA kit (3.5-hour, day-test format) for quantitative determination of DKK-1 in human serum; allows direct measurement without sample pre-dilution.
• FGF23 ELISA Kits (Intact and C-terminal) ELISA assays for measuring FGF23 in intact and C-terminal forms; used for investigating bone metabolism and cancer-induced bone diseases.
• LRG1 ELISA Kit (BI-LRG) ELISA for measuring Leucine-rich alpha-2-glycoprotein (LRG1) in cardiovascular research; no sample pre-dilution required, controls included.
• Human IL-6 ELISA Kit (BI-IL6) ELISA for measuring human IL-6 in serum and plasma with ready-to-use calibrators and controls.
• NT-proANP ELISA Kit (BI-20892) ELISA kit for NT-proANP measurement in rat and mouse samples.
• NT-proCNP ELISA Kit (BI-20812) ELISA kit for NT-proCNP measurement.
• Periostin ELISA Kit ELISA for periostin measurement in bone and cancer research.
• Free Soluble RANKL ELISA Kit ELISA for measuring free soluble RANKL.
• EZ4U Cell Proliferation and Cytotoxicity Assay (BI-5000) Assay kit for cell proliferation and cytotoxicity measurement.
• ELISA Analytical Testing Service Custom analytical testing service performed at the Bratislava facility for ELISA assays, covering both Biomedica's own kits and other manufacturers' ELISAs.
• Luminex Analytical Service Custom analytical testing service using Luminex bead-based technology for multiplexed biomarker measurement.
• MicroRNA Analytical Service Custom microRNA analysis service including osteomiR, thrombomiR, and toxomiR biomarker detection in serum and plasma samples.
• Glycan Profiling Service Lectin-based microarray (LecChip) service for glycan profiling using Glycotechnica's proprietary technology.
• Custom Immunoassay Development Service Contract development service for novel immunoassay development or professional advancement of existing tests, for customers, institutions, and companies requiring custom assays.

Quantifiable outcome

• Within-run precision ≤6% CV; In-between-run precision ≤4% CV for Rat NT-proBNP ELISA
• +2 more outcomes

Named customers3 records

Segments6 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature5 records

Partnerships

Five partnerships are on record, tiered core and minor.

• The Antibody Lab GmbHcoreTechnology or IntegrationLong-term partner in assay development based in Vienna. The company works closely with The Antibody Lab to select, develop, and establish new biomarker assays using their patented BestCell expression system for antibody production.
• TAmiRNAcoreChannel Partner/ Reseller/ DistributorVienna-based startup specializing in detection of microRNA biomarkers. Biomedica acts as global distributor for TAmiRNA products including osteomiR, thrombomiR, and toxomiR kits for detecting microRNA biomarkers in serum and plasma samples.
• FianosticscoreChannel Partner/ Reseller/ DistributorAustrian startup developing and producing patented FluoBolt high sensitivity fluorescence immunoassays for analytes hard to detect by conventional ELISA. Currently available: FluoBolt Noggin FIA, FluoBolt Periostin FIA, and FluoBolt Asporin FIA. Biomedica is global distributor.
• Glycotechnica LtdminorChannel Partner/ Reseller/ DistributorJapanese biotechnology company with proprietary lectin-based microarray technology (LecChip) for quick and accurate glycan profiling. Biomedica is exclusive European partner.
• AddLife GroupcoreOthersPublicly traded parent company consisting of various subsidiaries in Life Science and Medical Device fields. AddLife strives to improve people's lives by being a leading value-creating player in Life Science.

Scale indicators4 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• Bio-Techne (R&D Systems): Bio-Techne's R&D Systems brand is one of the largest specialty immunoassay/ELISA kit manufacturers serving biomedical research. Directly comparable to Biomedica in core technology (sandwich ELISA), target customer (researchers and pharma R&D), and broad biomarker catalog across immunology, oncology, and metabolic disease.
• Abcam: Research reagent supplier offering ELISA kits, matched antibody pairs, and recombinant proteins for biomarker detection. Comparable customer base (academic and pharma researchers), similar reliance on validation and citations, and overlapping product categories in cytokines, bone, and cardiovascular biomarkers.
• BioLegend (part of Revvity): Specialty manufacturer of ELISA kits, Luminex multiplex panels, and recombinant proteins focused on immunology, oncology, and cell biology. Closely comparable product mix, similar customer profile, and similar mid-size scale within the research reagent segment.
• Enzo Life Sciences: Specialty provider of ELISA kits, antibody products, and assay services for immunology, inflammation, oxidative stress, and cancer research. Overlaps directly with Biomedica's catalog ELISA business and shares a similar mid-cap, specialty-research positioning.
• RayBiotech: Manufacturer of ELISA, Luminex, and antibody arrays for biomarker discovery, with strong overlap in cytokine, inflammation, and angiogenesis panels. Directly comparable in Luminex multiplex service offering and research-use-only positioning.

Broad incumbents

• Thermo Fisher Scientific (Invitrogen / Thermo Scientific ELISA): Broad life-sciences incumbent offering ELISA kits, Luminex multiplex assays, and custom immunoassay services through its Bioscience and PPD divisions. Overlaps with Biomedica across catalog kits, antibody pairs, and biomarker services, but at significantly larger scale and broader portfolio.
• Merck KGaA / MilliporeSigma: Diversified life-sciences supplier offering ELISA kits, Luminex multiplex assays (MILLIPLEX), and custom immunoassay services under the MilliporeSigma brand. Comparable across catalog kits, services business, and pharma/biotech customer segments, though within a much larger chemicals and tools portfolio.

Emerging players

• Elabscience: Fast-growing China-based ELISA and reagent supplier offering broad catalog kits at aggressive pricing. Increasingly competitive with Biomedica in commodity biomarker categories, particularly for budget-sensitive academic accounts.
• CUSABIO: China-based ELISA kit and antibody manufacturer with an extensive catalog spanning cardiovascular, bone metabolism, cytokines, and oncology. Comparable product breadth to Biomedica, typically priced lower, putting pressure on Biomedica's mid-premium positioning.
• MyBioSource: Online-distributed ELISA kits and antibody products serving academic and preclinical researchers globally. Competes with Biomedica in catalog ELISA sales, particularly via e-commerce and budget-oriented accounts, though typically with less depth in proprietary validation.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/biomedica-immunoassays

Compliance4 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Biomedica